Some of the best technologies developed take their inspiration from the natural environment, and Limax Biosciences is following in this vein, with their novel hydrogel glue seeking to transform how we treat injuries inside and outside the body.

Co-founder Ben Freedman steps into this episode’s guest seat to share his mission of putting an end to disruptive and excessive bleeding that creates substantial costs for the healthcare system. With multiple applications for their innovation, significant progress has already been made towards closing the gap on hard to address vascular bleeds.

The Limax hydrogel has been shown to be capable of adhering to a bloody and beating pig heart, highlighting the unprecedented strong and flexible adhesion capabilities. Add to this, its biocompatible and antimicrobial features, and you can see why this technology is backed as one to watch by those in the industry.

If you want to learn more about the Latin foundation of their solution and expand your knowledge of medtech mimicry then this episode is sure to tick all those boxes and more!